Implementation of Epidemic Restrictions to Disrupt the COVID-19 Pandemic in Iran: A Mini-Review
Archives of Medical Laboratory Sciences,
Vol. 6 (2020),
20 Dey 2020
,
Page 1-3 (e11)
https://doi.org/10.22037/amls.v6.32966
Abstract
The number of cases infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes COVID-19, has been steadily rising globally. Iran, one of the countries with a relatively high number of positive cases, has an inevitable role to play in controlling the pandemic by implementing effective policies and countermeasures to interrupt the viral transmission chain. Epidemic restrictions implemented following an Iranian presidential mandate were especially effective following the Nowruz holidays—the solar New Year celebration in the Persian-speaking culture. These restrictions started flattening the incidence curve of the epidemic in Iran two weeks after implementation, from 10 April 2020. Supplying sufficient face masks, disinfectants, sanitizers, and medical equipment to all government-run and non-for-profit hospitals were included in the presidential mandate. We believe that continuing this policy strictly will be required for further controlling the pandemic throughout the country.
*Corresponding Author: Amin Talebi Bezmin Abadi; Email: amin.talebi@modares.ac.ir
Please cite this article as: Talebi Bezmin Abadi A, Rahimi F. Implementation of Epidemic Restrictions to Disrupt the COVID-19 Pandemic in Iran: A Mini-Review. Arch Med Lab Sci. 2020;6:e11. https://doi.org/10.22037/amls.v6.32966
- COVID-19
- Social Distancing
- Iran
- Pandemic
- SARS-CoV-2
How to Cite
References
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020 Mar 11. doi:10.1016/S0140-6736(20)30566-3
Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LE, Dar O, Arruda LB, Zumla A. 2019-nCoV in context: lessons learned?. The Lancet Planetary Health. 2020 Mar 1;4(3):e87-8. doi:10.1016/S2542-5196(20)30035-8.
Yeager A. Lost smell and taste hint COVID-19 can target the nervous system. The Scientist. 2020 Mar 24.
Jarvis C. The unusual symptoms of COVID-19. The Scientist. 2020. https://www.the-scientist.com/news-opinion/the-unusual-symptoms-of-covid-19-67522. Accessed 21 May 2020.
Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012 Jul;487(7408):477-81.. doi:10.1038/nature11228.
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020 May 12;75(18):2352-71. doi:10.1016/j.jacc.2020.03.031.
Hulot JS. COVID-19 in patients with cardiovascular diseases. Archives of cardiovascular diseases. 2020 Apr;113(4):225.
South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. American Journal of Physiology-Heart and Circulatory Physiology. 2020 Apr 13.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020 May;17(5):259-60. doi:10.1038/s41569-020-0360-5.
Pianegonda E. What is Kawasaki disease, what are the symptoms and is it linked to coronavirus?–ABC News. 2020. https://www.abc.net.au/news/2020-04-29/kawasaki-disease-symptoms-is-it-linked-coronavirus-in-australia/12197008. Accessed 30 April 2020.
He X, Lau EH, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, Mo X. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature medicine. 2020 May;26(5):672-5. doi:10.1038/s41591-020-0869-5.
Yu C, Zhou M, Liu Y, Guo T, Ou C, Yang L, Li Y, Li D, Hu X, Shuai L, Wang B. Characteristics of asymptomatic COVID-19 infection and progression: a multicenter, retrospective study. Virulence. 2020 Jan 1;11(1):1006-14.
Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel medicine and infectious disease. 2020 Feb 27. doi:10.1016/j.tmaid.2020.101608.
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020 Apr 14;323(14):1406-7. doi:10.1001/jama.2020.2565.
The World Health Organization. Coronavirus disease (COVID-19) 2020 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 7 December 2020.
Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ, Sun F, Flasche S. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health. 2020 Feb 28. . doi:10.1016/S2214-109X(20)30074-7.
Official website of the President of the Islamic Republic of Iran. Close monitoring of provinces in which Smart Social Distancing will be implemented essential/no new decision made for Tehran province.2020. http://www.president.ir/en/114676. Accessed April 24 2020.
The World Health Organization Coronavirus disease (COVID-19) Situation Report 2020–51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_6. Accessed 14 April 2020.
Reuters Editorial. Iran locks down southwest county after spike in coronavirus cases. Reuters. https://www.reuters.com/article/us-health-coronavirus-iran-idUSKBN22M0Q7. Accessed 22 May 2020.
Worldometer. Coronavirus (COVID-19) mortality rate. Dadax. https://www.worldometers.info/coronavirus/. Accessed 25 April 2020.
- Abstract Viewed: 129 times
- PDF Downloaded: 69 times